ANRIL reduces the expression of miR-125a by binding to it. In the Alzheimer's disease model, ANRIL silencing increases neurite outgrowth and suppresses cell apoptosis and inflammation. The gene discussed is CDKN2B-AS1; the disease is early-onset autosomal dominant Alzheimer disease.